Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Epidermal Cyst | 1 | 2018 | 10 | 0.76 | Why? |
| Molluscum Contagiosum | 1 | 2018 | 11 | 0.76 | Why? |
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2017 | 11 | 0.71 | Why? |
| Cell Transformation, Viral | 1 | 2017 | 21 | 0.70 | Why? |
| Cellular Microenvironment | 1 | 2017 | 55 | 0.70 | Why? |
| Oncogene Proteins, Viral | 1 | 2017 | 36 | 0.68 | Why? |
| Papillomavirus Infections | 4 | 2019 | 861 | 0.66 | Why? |
| Keratinocytes | 1 | 2017 | 119 | 0.64 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.63 | Why? |
| Carcinoma, Squamous Cell | 4 | 2019 | 902 | 0.38 | Why? |
| Uterine Cervical Neoplasms | 1 | 2017 | 842 | 0.37 | Why? |
| Epidermodysplasia Verruciformis | 2 | 2017 | 7 | 0.36 | Why? |
| Penile Neoplasms | 2 | 2019 | 97 | 0.35 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.34 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.27 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.27 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.26 | Why? |
| Opportunistic Infections | 2 | 2018 | 602 | 0.22 | Why? |
| Tumor Virus Infections | 2 | 2018 | 127 | 0.20 | Why? |
| BK Virus | 2 | 2018 | 135 | 0.20 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.20 | Why? |
| Polyomavirus Infections | 2 | 2018 | 156 | 0.20 | Why? |
| Molluscum contagiosum virus | 1 | 2018 | 2 | 0.19 | Why? |
| Buschke-Lowenstein Tumor | 1 | 2018 | 3 | 0.19 | Why? |
| Human papillomavirus 6 | 1 | 2018 | 8 | 0.19 | Why? |
| Cytosine Deaminase | 1 | 2018 | 14 | 0.19 | Why? |
| Pneumocystis carinii | 1 | 2021 | 205 | 0.19 | Why? |
| Aneuploidy | 1 | 2018 | 27 | 0.18 | Why? |
| Granulocytes | 1 | 2019 | 140 | 0.18 | Why? |
| alpha 1-Antitrypsin | 1 | 2021 | 264 | 0.18 | Why? |
| Chromatin Immunoprecipitation | 1 | 2017 | 53 | 0.18 | Why? |
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 56 | 0.18 | Why? |
| SOXB1 Transcription Factors | 1 | 2017 | 20 | 0.17 | Why? |
| Cytotoxicity, Immunologic | 1 | 2019 | 287 | 0.17 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2019 | 349 | 0.17 | Why? |
| Papillomaviridae | 2 | 2019 | 404 | 0.16 | Why? |
| Immunoblotting | 1 | 2017 | 180 | 0.16 | Why? |
| Biological Ontologies | 1 | 2018 | 77 | 0.16 | Why? |
| Anus Neoplasms | 1 | 2018 | 123 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Pneumonia, Pneumocystis | 1 | 2021 | 322 | 0.16 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.16 | Why? |
| In Situ Hybridization | 1 | 2017 | 390 | 0.15 | Why? |
| Membrane Transport Proteins | 1 | 2017 | 152 | 0.15 | Why? |
| Chromosomes, Human, Pair 3 | 1 | 2017 | 195 | 0.14 | Why? |
| Head and Neck Neoplasms | 2 | 2018 | 1568 | 0.14 | Why? |
| Data Accuracy | 1 | 2020 | 715 | 0.14 | Why? |
| Cardiology Service, Hospital | 1 | 2020 | 602 | 0.13 | Why? |
| Herpes Zoster | 1 | 2018 | 331 | 0.12 | Why? |
| Graft vs Host Disease | 1 | 2017 | 501 | 0.12 | Why? |
| Biological Dressings | 1 | 2012 | 2 | 0.12 | Why? |
| Corneal Stroma | 1 | 2012 | 26 | 0.12 | Why? |
| Leukemia | 1 | 2017 | 598 | 0.12 | Why? |
| Cerebrovascular Disorders | 1 | 2020 | 1040 | 0.12 | Why? |
| Amnion | 1 | 2012 | 55 | 0.11 | Why? |
| Corneal Ulcer | 1 | 2012 | 50 | 0.11 | Why? |
| Vasculitis | 1 | 2018 | 691 | 0.11 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2020 | 11367 | 0.11 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.10 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.09 | Why? |
| Viral Envelope Proteins | 1 | 2020 | 3539 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2019 | 3567 | 0.08 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.08 | Why? |
| Immune Evasion | 1 | 2017 | 2081 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.08 | Why? |
| HIV-1 | 1 | 2021 | 3365 | 0.08 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.08 | Why? |
| Cell Line | 2 | 2018 | 12040 | 0.07 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.07 | Why? |
| Skin Neoplasms | 1 | 2017 | 1679 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Humans | 22 | 2021 | 930598 | 0.06 | Why? |
| Trypsin Inhibitors | 1 | 2021 | 38 | 0.06 | Why? |
| Skin Diseases | 1 | 2018 | 2509 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.05 | Why? |
| Germany | 3 | 2021 | 9196 | 0.05 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.05 | Why? |
| Neoplasm Staging | 2 | 2019 | 1999 | 0.05 | Why? |
| CD47 Antigen | 1 | 2019 | 47 | 0.05 | Why? |
| Human Papillomavirus DNA Tests | 1 | 2018 | 12 | 0.05 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.05 | Why? |
| Comparative Genomic Hybridization | 1 | 2018 | 33 | 0.05 | Why? |
| Emergency Service, Hospital | 2 | 2021 | 14232 | 0.05 | Why? |
| Intercellular Adhesion Molecule-1 | 1 | 2019 | 189 | 0.05 | Why? |
| APOBEC Deaminases | 1 | 2018 | 58 | 0.04 | Why? |
| Chromosome Mapping | 1 | 2018 | 178 | 0.04 | Why? |
| Cytidine Deaminase | 1 | 2018 | 109 | 0.04 | Why? |
| Random Allocation | 1 | 2020 | 773 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2018 | 5397 | 0.04 | Why? |
| Mice | 1 | 2017 | 21357 | 0.04 | Why? |
| Toxoplasma | 1 | 2017 | 61 | 0.04 | Why? |
| JC Virus | 1 | 2017 | 39 | 0.04 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2018 | 207 | 0.04 | Why? |
| Cystitis | 1 | 2017 | 45 | 0.04 | Why? |
| ErbB Receptors | 1 | 2019 | 320 | 0.04 | Why? |
| Alemtuzumab | 1 | 2017 | 121 | 0.04 | Why? |
| Herpesvirus 3, Human | 1 | 2018 | 228 | 0.04 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.04 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.04 | Why? |
| Capsid Proteins | 1 | 2018 | 365 | 0.04 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.03 | Why? |
| Lymphatic Metastasis | 1 | 2017 | 537 | 0.03 | Why? |
| Transplantation, Homologous | 1 | 2017 | 757 | 0.03 | Why? |
| Male | 10 | 2021 | 367725 | 0.03 | Why? |
| Clinical Laboratory Services | 1 | 2020 | 781 | 0.03 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Pharynx | 1 | 2020 | 1544 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.03 | Why? |
| Animals | 2 | 2018 | 78931 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2018 | 1706 | 0.03 | Why? |
| Kinetics | 1 | 2019 | 3238 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1014 | 0.03 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2017 | 676 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Prognosis | 3 | 2019 | 32490 | 0.03 | Why? |
| Aged | 7 | 2021 | 215776 | 0.02 | Why? |
| Female | 7 | 2021 | 380317 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2019 | 4260 | 0.02 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Child | 1 | 2018 | 70012 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2017 | 1314 | 0.02 | Why? |
| DNA, Viral | 1 | 2018 | 2521 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Kidney Diseases | 1 | 2018 | 1434 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Software | 1 | 2018 | 2501 | 0.02 | Why? |
| World Health Organization | 1 | 2019 | 4213 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Neutrophils | 1 | 2019 | 5476 | 0.02 | Why? |
| Patient Acceptance of Health Care | 1 | 2020 | 5002 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Adult | 4 | 2019 | 244371 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2019 | 88759 | 0.01 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Italy | 1 | 2018 | 38444 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2018 | 25288 | 0.01 | Why? |
Smola's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(117)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_